FN1 and cancer: This process takes place as cancer develops, and it involves a decrease in the expression of molecules associated with epithelial growth, such as E-cadherin, and a rise in molecules associated with mesenchymal development, such as N-cadherin, vimentin (VIM), and fibronectin (FN1) (156).